Federal Register - October 1, 2021
Version en texte Qu'est-ce que c'est?Dateas est un site Web indépendant, non affilié à un organisme gouvernemental. La source des documents PDF que nous publions est l'agence officielle indiquée dans chacun d'eux. Les versions en texte sont des transcriptions non officielles que nous faisons pour fournir de meilleurs outils d'accès et de recherche d'informations, mais peuvent contenir des erreurs ou peuvent ne pas être complètes.
Source: Federal Register
54566
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. at 26876; GX 28, p. 8.
Treatment of Patient B.F.
27. Pharmacy 4 Less dispensed hydromorphone to Patient B.F. on 17
occasions between October 27, 2015, and May 15, 2017. GX 12.
28. On October 27, 2015, Pharmacy 4
Less dispensed Patient B.F. 64 tablets of hydromorphone 8 mg without determining whether Patient B.F. was opioid nave. Tr. at 21718; GX 28, p.
10; GX 38, p. 5.
29. Between November 24, 2015, and May 15, 2017, Pharmacy 4 Less, on 16
separate occasions, dispensed hydromorphone 8 mg tablets to Patient B.F. at a price of approximately $5.70 to $5.83 per tablet, even though other retail pharmacies were selling hydromorphone 8 mg at approximately $1.50 per tablet at the time. Tr. at 218
22; GX 28, p. 11.
30. Between December 30, 2015, and May 15, 2017, Pharmacy 4 Less, on 15
separate occasions, dispensed hydromorphone to Patient B.F. without determining why hydromorphone was being prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. 21922; GX 28, p.
10.
Treatment of Patient B.N.
31. Pharmacy 4 Less dispensed either hydromorphone or oxycodone to Patient B.N. on 19 occasions between January 22, 2016, and June 2, 2017. GX 14.
32. On January 22, 2016, Pharmacy 4
Less dispensed to Patient B.N. 90 tablets of hydromorphone 8 mg without determining whether Patient B.F. was opioid nave. Tr. 22227; GX 28, p. 14.
33. Between January 22, 2016, and August 15, 2016, Pharmacy 4 Less, on nine separate occasions, dispensed hydromorphone 8 mg tablets to Patient B.N. at a price of approximately $5.95
to $6.45 per tablet, even though other retail pharmacies were selling hydromorphone 8 mg at approximately $1.50 per tablet at the time. Tr. 22235;
GX 28, p. 15.
34. Between September 9, 2016, and June 2, 2017, Pharmacy 4 Less, on ten separate occasions, dispensed oxycodone 30 mg tablets to Patient B.N.
at a price of approximately $5.00 per tablet, even though other retail pharmacies were selling oxycodone 30
mg tablets at approximately $0.90 per tablet at the time; Tr. 23235; GX 28, p.
15.
35. Between March 15, 2016, and June 2, 2017, Pharmacy 4 Less, on 17
separate occasions, dispensed hydromorphone and oxycodone to
VerDate Sep<11>2014
20:19 Sep 30, 2021
Jkt 256001
Patient B.N. without determining why hydromorphone and oxycodone were being prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. 22235; GX 28, pp.
1415.
Treatment of Patient K.E.D.
36. Pharmacy 4 Less dispensed oxycodone to Patient K.E.D. on 21
occasions between October 26, 2015, and June 7, 2017. GX 18.
37. On October 26, 2015, Pharmacy 4
Less dispensed to Patient K.E.D. 112
tablets of oxycodone 20.5 mg without determining whether Patient K.E.D. was opioid nave. Tr. 24144; GX 28, p. 16;
GX 38, p. 7.
38. Between October 26, 2015, and June 7, 2017, Pharmacy 4 Less, on 21
separate occasions, dispensed oxycodone 20 mg tablets to Patient K.E.D. at a price of approximately $3.57
to $3.84 per tablet, even though other retail pharmacies were selling oxycodone 20 mg at approximately $0.90 per tablet at the time. Tr. 24147;
GX 28, p. 17.
39. Between December 21, 2015, and June 7, 2017, Pharmacy 4 Less, on 19
separate occasions, dispensed oxycodone to Patient K.E.D. without determining why oxycodone was being prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. 24447; GX 28, pp. 16
17.
Treatment of Patient K.Y.D.
40. Pharmacy 4 Less dispensed oxycodone to Patient K.Y.D. on 17
occasions between February 4, 2016, and June 12, 2017. GX 16.
41. On February 4, 2016, Pharmacy 4
Less dispensed to Patient K.Y.D. 84
tablets of oxycodone 30 mg without determining whether Patient K.Y.D. was opioid nave. Tr. 23738; GX 28, p. 20.
42. Between February 4, 2016, and June 12, 2017, Pharmacy 4 Less, on 17
separate occasions, dispensed oxycodone 30 mg tablets to Patient K.Y.D. at a price of approximately $3.45
per tablet, even though other retail pharmacies were selling oxycodone 30
mg at approximately $0.90 per tablet at the time. Tr. 23741; GX 28, pp. 2021.
43. Between March 31, 2016, and June 12, 2017, Pharmacy 4 Less, on 15
separate occasions, dispensed oxycodone to Patient K.Y.D. without determining why oxycodone was being prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. 23741; GX, p. 20.
Treatment of Patient R.R.
44. Pharmacy 4 Less dispensed oxycodone to Patient R.R. on 21
PO 00000
Frm 00018
Fmt 4701
Sfmt 4703
occasions between October 28, 2015, and May 30, 2017. GX 20.
45. On October 28, 2015, Pharmacy 4
Less dispensed to Patient R.R. 112
tablets of oxycodone 18 mg without determining whether Patient R.R. was opioid nave. Tr. 24750; GX 28, p. 18;
GX 38, p. 8.
46. Between November 23, 2015, and May 30, 2017, Pharmacy 4 Less, on 20
separate occasions, dispensed oxycodone 15 mg tablets BB to Patient R.R. at a price of approximately $2.28 to $2.41 per tablet, even though other retail pharmacies were selling oxycodone 15
mg at approximately $0.90 per tablet at the time. Tr. 24750; GX 28, p. 19.
47. Between December 21, 2015, and May 30, 2017, Pharmacy 4 Less, on 19
separate occasions, dispensed oxycodone to Patient R.R. without determining why oxycodone was being prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. 24850; GX 28, pp. 18
19.
Treatment of Patient R.V.
48. Pharmacy 4 Less dispensed oxycodone to Patient R.V. on 22
occasions between November 17, 2015, and June 19, 2017. GX 22.
49. On November 17, 2015, Pharmacy 4 Less dispensed to Patient R.V. 112
tablets of oxycodone 20 mg without determining whether Patient R.V. was opioid nave. Tr. 25153; GX 28, p. 22;
GX 38, p. 7.
50. Between November 17, 2015, and June 19, 2017, Pharmacy 4 Less, on 21
separate occasions,45 dispensed oxycodone 20 mg tablets CC to Patient R.V. at a price of approximately $2.23 to $3.04 per tablet, even though other retail pharmacies were selling oxycodone 20
mg at approximately $0.90 per tablet at the time. Tr. 25155; GX 28, pp. 2223.
51. Between January 11, 2016, and June 19, 2017, Pharmacy 4 Less, on 20
separate occasions, dispensed oxycodone to Patient R.V. without determining why oxycodone was being prescribed on a long-term basis without the presence of a long-acting pain medication. Tr. 25255; GX 28, p. 22.
Treatment of Patient V.W.
52. Pharmacy 4 Less dispensed oxycodone to Patient V.W. on 21
occasions between November 30, 2015, and May 31, 2017. GX 24.
BB Additionally, on October 28, 2015, Pharmacy 4 Less, dispensed oxycodone 18 mg tablets to Patient R.R. at a price of approximately $2.23.
45 The Government is not alleging that the price charged on March 27, 2017 was unreasonable.
CC Except for on April 22, 2017, when Oxycodone 15 mg was dispensed at a price of $2.23
per tablet. GX 22, p. 71.
E:FRFM01OCN2.SGM
01OCN2
